Marta Huguet-Anglada
Bonn, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Fragmentation of functional resting state brain networks in a transgenic mouse model of tau pathology: A metabolic connectivity study using [18F]FDG-PET.
Journal: Experimental neurology
Published: August 24, 2023
Spreading of Tau Protein Does Not Depend on Aggregation Propensity.
Journal: Journal of molecular neuroscience : MN
Published: May 26, 2023
Reversal of Tau-Dependent Cognitive Decay by Blocking Adenosine A1 Receptors: Comparison of Transgenic Mouse Models with Different Levels of Tauopathy.
Journal: International journal of molecular sciences
Published: March 16, 2023
Assessment of the In Vivo Relationship Between Cerebral Hypometabolism, Tau Deposition, TSPO Expression, and Synaptic Density in a Tauopathy Mouse Model: a Multi-tracer PET Study.
Journal: Molecular neurobiology
Published: November 02, 2021
Inhibition of Tau aggregation with BSc3094 reduces Tau and decreases cognitive deficits in rTg4510 mice.
Journal: Alzheimer's & dementia (New York, N. Y.)
Published: February 21, 2021
RTP801/REDD1 contributes to neuroinflammation severity and memory impairments in Alzheimer's disease.
Journal: Cell death & disease
Published: November 19, 2020
Functional networks are impaired by elevated tau-protein but reversible in a regulatable Alzheimer's disease mouse model.
Journal: Molecular neurodegeneration
Published: December 20, 2018
Anti-aggregant tau mutant promotes neurogenesis.
Journal: Molecular neurodegeneration
Published: September 26, 2017
Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau ΔK280.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 28, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026